Shareholding disclosure

UBS AG

Declared position

6.72%

Threshold

Crossed upwards

Timeline

Published

11.03.2014

Transaction

28.02.2014

Transfer date

28.02.2014

Voting rights breakdown

Voting rights acquired6.72%

Voting rights sold2.1%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE3700050

Beneficial owner

UBS AG

Declared address

UBS AG, 8098 Zürich

Aktueller Weblink: chttp://www.galenica.com/wAssetsGalenica/bin/shared/f52b5e449a2303c031a0c3a1109360bf/20140228-Galenica-AG-Annexes.pdf

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

UBS AG

Vifor Pharma AG11.03.2014TAE3700050

Disclosure summary

UBS AG disclosed a holding in Vifor Pharma AG on the acquisition side, published by SIX Exchange Regulation on 11.03.2014, at 6.72% of voting rights. Notice category: Single shareholder.

Disclosed position

6.72%

Voting rights acquired

Voting rights acquired6.72%

Voting rights sold2.1%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

UBS AG disclosed a holding in Vifor Pharma AG, published on 11.03.2014.

Publication date11.03.2014

Transaction date28.02.2014

Transfer date28.02.2014

Issuing companyVifor Pharma AG

Beneficial ownerUBS AG

Declared addressUBS AG, 8098 Zürich

CategorySingle shareholder

Voting rights acquired6.72%

Voting rights sold2.1%

Below threshold0%

ExchangeXSWX

Notification IDTAE3700050

Commercial register

CHE-101.329.561

Registered

Zefix record

Conditions

Aktueller Weblink: chttp://www.galenica.com/wAssetsGalenica/bin/shared/f52b5e449a2303c031a0c3a1109360bf/20140228-Galenica-AG-Annexes.pdf

Source: SIX Exchange Regulation · Publication date: 11.03.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open